Safety Action Feedback and Engagement (SAFE) Loop for Medication Errors

Phase-Based Progress Estimates
Cedars-Sinai Medical Center, Los Angeles, CA
Medication Errors+1 More
Safety Action Feedback and Engagement (SAFE) Loop - Behavioral
Any Age
All Sexes
What conditions do you have?

Study Summary

This trial will test whether a new intervention, the Safety Action Feedback and Engagement (SAFE) Loop, enhances nurse incident reporting practices, improves nurses' perceptions of incident reporting, and lowers rates of high-priority medication events, as compared with using an existing incident reporting system. The trial will be performed in 20 acute care nursing units at Cedars-Sinai Medical Center.

Eligible Conditions

  • Medication Errors
  • Patient's Safety

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Medication Errors

Study Objectives

3 Primary · 3 Secondary · Reporting Duration: 48 weeks

24 weeks
Nurses' attitudes regarding communication about error
Nurses' attitudes regarding reporting of patient safety events
48 weeks
Nurses' incident reporting practices
Rate of high-priority medication events
Rate of high-priority medication events that involved patient harm
Rate of reporting high-priority medication events

Trial Safety

Safety Progress

1 of 3

Other trials for Medication Errors

Trial Design

2 Treatment Groups

Control Arm
1 of 2
SAFE Loop Arm
1 of 2
Active Control
Experimental Treatment

5163 Total Participants · 2 Treatment Groups

Primary Treatment: Safety Action Feedback and Engagement (SAFE) Loop · No Placebo Group · N/A

SAFE Loop Arm
Experimental Group · 1 Intervention: Safety Action Feedback and Engagement (SAFE) Loop · Intervention Types: Behavioral
Control ArmNoIntervention Group · 1 Intervention: Control Arm · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 48 weeks
Closest Location: Cedars-Sinai Medical Center · Los Angeles, CA
Photo of Los Angeles 1Photo of Los Angeles 2Photo of Los Angeles 3
2006First Recorded Clinical Trial
1 TrialsResearching Medication Errors
515 CompletedClinical Trials

Who is running the clinical trial?

Agency for Healthcare Research and Quality (AHRQ)FED
356 Previous Clinical Trials
6,987,380 Total Patients Enrolled
6 Trials studying Medication Errors
8,340 Patients Enrolled for Medication Errors
Cedars-Sinai Medical CenterLead Sponsor
449 Previous Clinical Trials
139,158 Total Patients Enrolled
Carl Berdahl, MDStudy DirectorPhysician Scientist, Cedars-Sinai
Teryl K Nuckols, MDPrincipal InvestigatorVice Chair for Clinical Research Dept of Medicine, Cedars-Sinai

Eligibility Criteria

Age Any Age · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
All 1,980 nurses on the nursing units will be eligible to participate.
We will enroll 32 participants out of a pool of approximately 800 eligible nurses.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.